Health Care - As introduced, lowers from every three years to every two years, the time within which the advisory committee composed of medical device industry representatives and a representative of the department of economic and community development must review rules regarding the board of pharmacy's oversight of facilities that manufacture, warehouse, and distribute medical devices in order to review the advancements of new medical device technologies. - Amends TCA Title 8; Title 47; Title 56; Title 63 and Title 71.

Introduced

In Committee

Floor

Crossed Over

Passed

Enacted

Overview Bill text 3 Compare versions History 21 Sponsors

No summary has been published for this bill. The full text is on the Bill text tab.

Chamber: Senate
Introduced: Jan 28, 2025
Last action: Apr 20, 2026 — Assigned to General Subcommittee of Senate Finance, Ways, and Means Committee
Session: 114
Momentum: 36 · Low

PASSAGE PROBABILITY

25.9% Uncertain

Why this number

Stage base In Committee — base rate 51%, measured from TN's completed sessions
Momentum -3 36/100 from the pace of recorded action
Time since last action -22 176 days quiet

A transparent scoring model over stage, momentum, recency, sponsorship and recorded votes — not a trained predictor. Treat it as a way to rank attention, not as a forecast.